BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21814161)

  • 1. Inhibitory effect and possible mechanism of action of patchouli alcohol against influenza A (H2N2) virus.
    Wu H; Li B; Wang X; Jin M; Wang G
    Molecules; 2011 Aug; 16(8):6489-501. PubMed ID: 21814161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth.
    Kiyohara H; Ichino C; Kawamura Y; Nagai T; Sato N; Yamada H
    J Nat Med; 2012 Jan; 66(1):55-61. PubMed ID: 21671149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
    Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
    Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition effects of patchouli alcohol against influenza a virus through targeting cellular PI3K/Akt and ERK/MAPK signaling pathways.
    Yu Y; Zhang Y; Wang S; Liu W; Hao C; Wang W
    Virol J; 2019 Dec; 16(1):163. PubMed ID: 31870450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
    J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.
    Farooqui A; Huang L; Wu S; Cai Y; Su M; Lin P; Chen W; Fang X; Zhang L; Liu Y; Zeng T; Paquette SG; Khan A; Kelvin AA; Kelvin DJ
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7255-64. PubMed ID: 26369969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies.
    Yang Z; Wu F; Yuan X; Zhang L; Zhang S
    J Mol Graph Model; 2016 Apr; 65():27-34. PubMed ID: 26905206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
    Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
    J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition.
    Guo M; Ni J; Yu J; Jin J; Ma L; Zhang H; Wang D; Zhang X; Dou J; Zhou C
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
    Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.
    Belser JA; Sleeman K; Pearce MB; Katz JM; Gubareva LV; Tumpey TM
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1616-8. PubMed ID: 22155827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
    Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
    Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
    Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.